Latest Insider Transactions at Nabriva Therapeutics PLC (NBRV)

This section provides a real-time view of insider transactions for Nabriva Therapeutics PLC (NBRV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Nabriva Therapeutics plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Nabriva Therapeutics plc's insiders and make more informed investment decisions.

Insider Transaction List

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Jul 28 2021	Daniel D Burgess Director	BUY Grant, award, or other acquisition	Direct	17,500 +43.37%	-
Jul 06 2021	Robert Crotty Gen Counsel & Corp Secretary	SELL Payment of exercise price or tax liability	Direct	74 -0.18%	$74 $1.27 P/Share
Jul 06 2021	Steven P. Gelone Director	SELL Payment of exercise price or tax liability	Direct	92 -0.03%	$92 $1.27 P/Share
Jul 06 2021	Theodore R Schroeder Director	SELL Payment of exercise price or tax liability	Direct	225 -0.13%	$225 $1.27 P/Share
Jun 30 2021	Robert Crotty Gen Counsel & Corp Secretary	SELL Payment of exercise price or tax liability	Direct	37 -0.09%	$37 $1.35 P/Share
Jun 30 2021	Steven P. Gelone Director	SELL Payment of exercise price or tax liability	Direct	63 -0.02%	$63 $1.35 P/Share
Jun 30 2021	Theodore R Schroeder Director	SELL Payment of exercise price or tax liability	Direct	107 -0.06%	$107 $1.35 P/Share
Jun 06 2021	Robert Crotty Gen Counsel & Corp Secretary	SELL Payment of exercise price or tax liability	Direct	73 -0.18%	$73 $1.34 P/Share
Jun 06 2021	Steven P. Gelone Director	SELL Payment of exercise price or tax liability	Direct	92 -0.03%	$92 $1.34 P/Share
Jun 06 2021	Theodore R Schroeder Director	SELL Payment of exercise price or tax liability	Direct	225 -0.13%	$225 $1.34 P/Share
May 31 2021	Steven P. Gelone Director	SELL Payment of exercise price or tax liability	Direct	63 -0.02%	$63 $1.38 P/Share
May 31 2021	Robert Crotty Gen Counsel & Corp Secretary	SELL Payment of exercise price or tax liability	Direct	37 -0.09%	$37 $1.38 P/Share
May 31 2021	Theodore R Schroeder Director	SELL Payment of exercise price or tax liability	Direct	107 -0.06%	$107 $1.38 P/Share
May 06 2021	Robert Crotty Gen Counsel & Corp Secretary	SELL Payment of exercise price or tax liability	Direct	74 -0.18%	$74 $1.49 P/Share
May 06 2021	Steven P. Gelone Director	SELL Payment of exercise price or tax liability	Direct	92 -0.03%	$92 $1.49 P/Share
May 06 2021	Theodore R Schroeder Director	SELL Payment of exercise price or tax liability	Direct	225 -0.13%	$225 $1.49 P/Share
Apr 30 2021	Theodore R Schroeder Director	SELL Payment of exercise price or tax liability	Direct	107 -0.06%	$107 $1.78 P/Share
Apr 30 2021	Steven P. Gelone Director	SELL Payment of exercise price or tax liability	Direct	63 -0.02%	$63 $1.78 P/Share
Apr 30 2021	Robert Crotty Gen Counsel & Corp Secretary	SELL Payment of exercise price or tax liability	Direct	37 -0.09%	$37 $1.78 P/Share
Apr 28 2021	Steven P. Gelone Director	BUY Grant, award, or other acquisition	Direct	290,697 +44.17%	-
Apr 06 2021	Robert Crotty Gen Counsel & Corp Secretary	SELL Payment of exercise price or tax liability	Direct	74 -0.18%	$74 $1.73 P/Share
Apr 06 2021	Steven P. Gelone Director	SELL Payment of exercise price or tax liability	Direct	92 -0.12%	$92 $1.73 P/Share
Apr 06 2021	Theodore R Schroeder Director	SELL Payment of exercise price or tax liability	Direct	225 -0.13%	$225 $1.73 P/Share
Mar 31 2021	Theodore R Schroeder Director	SELL Payment of exercise price or tax liability	Direct	107 -0.06%	$107 $1.66 P/Share
Mar 31 2021	Robert Crotty Gen Counsel & Corp Secretary	SELL Payment of exercise price or tax liability	Direct	37 -0.09%	$37 $1.66 P/Share
Mar 31 2021	Steven P. Gelone Director	SELL Payment of exercise price or tax liability	Direct	63 -0.08%	$63 $1.66 P/Share
Mar 06 2021	Robert Crotty Gen Counsel & Corp Secretary	SELL Payment of exercise price or tax liability	Direct	71 -0.17%	$71 $1.79 P/Share
Mar 06 2021	Steven P. Gelone Director	SELL Payment of exercise price or tax liability	Direct	92 -0.12%	$92 $1.79 P/Share
Mar 06 2021	Theodore R Schroeder Director	SELL Payment of exercise price or tax liability	Direct	225 -0.13%	$225 $1.79 P/Share
Feb 28 2021	Robert Crotty Gen Counsel & Corp Secretary	SELL Payment of exercise price or tax liability	Direct	38 -0.09%	$76 $2.39 P/Share
Feb 28 2021	Steven P. Gelone Director	SELL Payment of exercise price or tax liability	Direct	63 -0.08%	$126 $2.39 P/Share
Feb 28 2021	Jennifer Schranz Chief Medical Officer	SELL Payment of exercise price or tax liability	Direct	33 -0.08%	$66 $2.39 P/Share
Feb 28 2021	Theodore R Schroeder Director	SELL Payment of exercise price or tax liability	Direct	106 -0.06%	$212 $2.39 P/Share
Feb 28 2021	Gary Sender Chief Financial Officer	SELL Payment of exercise price or tax liability	Direct	31 -0.15%	$62 $2.39 P/Share
Feb 06 2021	Robert Crotty Gen Counsel & Corp Secretary	SELL Payment of exercise price or tax liability	Direct	870 -2.04%	$1,740 $2.9 P/Share
Feb 06 2021	Steven P. Gelone Director	SELL Payment of exercise price or tax liability	Direct	1,104 -1.41%	$2,208 $2.9 P/Share
Feb 06 2021	Theodore R Schroeder Director	SELL Payment of exercise price or tax liability	Direct	2,695 -1.48%	$5,390 $2.9 P/Share
Jan 31 2021	Gary Sender Chief Financial Officer	SELL Payment of exercise price or tax liability	Direct	37 -0.18%	$74 $2.62 P/Share
Jan 31 2021	Steven P. Gelone Director	SELL Payment of exercise price or tax liability	Direct	75 -0.1%	$150 $2.62 P/Share
Jan 31 2021	Jennifer Schranz Chief Medical Officer	SELL Payment of exercise price or tax liability	Direct	36 -0.09%	$72 $2.62 P/Share
Jan 31 2021	Theodore R Schroeder Director	SELL Payment of exercise price or tax liability	Direct	125 -0.07%	$250 $2.62 P/Share
Jan 31 2021	Robert Crotty Gen Counsel & Corp Secretary	SELL Payment of exercise price or tax liability	Direct	43 -0.1%	$86 $2.62 P/Share
Jan 29 2021	Steven P. Gelone Director	BUY Grant, award, or other acquisition	Direct	42,500 +35.2%	-
Jan 29 2021	Jennifer Schranz Chief Medical Officer	BUY Grant, award, or other acquisition	Direct	22,500 +36.47%	-
Jan 29 2021	Theodore R Schroeder Director	BUY Grant, award, or other acquisition	Direct	117,500 +39.23%	-
Jan 29 2021	Robert Crotty Gen Counsel & Corp Secretary	BUY Grant, award, or other acquisition	Direct	22,500 +34.45%	-
Dec 31 2020	Robert Crotty Gen Counsel & Corp Secretary	SELL Payment of exercise price or tax liability	Direct	37 -0.18%	$74 $2.42 P/Share
Dec 31 2020	Steven P. Gelone Director	SELL Payment of exercise price or tax liability	Direct	63 -0.18%	$126 $2.42 P/Share
Dec 31 2020	Jennifer Schranz Chief Medical Officer	SELL Payment of exercise price or tax liability	Direct	30 -0.18%	$60 $2.42 P/Share
Dec 31 2020	Theodore R Schroeder Director	SELL Payment of exercise price or tax liability	Direct	121 -0.19%	$242 $2.42 P/Share

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBRV shares.

Notify only if

Value

Insider Trading

Get notified when an Nabriva Therapeutics PLC insider buys or sells NBRV shares.

Notify only if

Operation

Value

Type

News

Receive news related to Nabriva Therapeutics plc

Track Activities on NBRV

Account

Latest Insider Transactions at Nabriva Therapeutics PLC (NBRV)

Insider Transaction List

Track Institutional and Insider Activities on NBRV

Institutional Portfolio Updates

Insider Trading

News